Mr Murphy, formerly vice president of finance and CFO at Princess House will report directly to James Northrop, president and CEO of Immunotec.
Prior to joining Immunotec, Mr Murphy held various senior operating positions in a variety of industries, focusing on financial management and process improvement methodologies.
The board of directors of Immunotec has approved the granting of 300,000 stock options to Mr Murphy under the company’s stock option plan, at a price of $0.56.
Mr Northrop said: “I am delighted that Dan will be assuming the role of COO at Immunotec. Dan has proven operational skills and brings with him a wealth of knowledge in our industry.”